Clinical Trial Update: A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

This document provides an update on a Phase III clinical trial evaluating nimotuzumab in combination with concurrent chemoradiotherapy for loco-regional esophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Prosthesis Survival | Phase 3 | Status: UNKNOWN